why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: April 24, 2025

Clinical Trial: Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Acute Allergic Reaction

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Safety, Tolerability and Pharmacokinetics of Various Doses of KP001 (Epinephrine Inhalation Aerosol) in Healthy

Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of several KP001 dose regimens to identify a treatment regimen with a PK profile that safely meets or exceeds the PK profile of existing injected epinephrine products.The main questions it aims to answer are:To evaluate any carryover effect with a 7-day washout of different dose regimens of KP001 in healthy adult volunteers.To evaluate the safety, tolerability and PK of different dose regimens of KP001 in healthy…

Read more